CEMB has taken a groundbreaking step by partnering with MIDAS through a newly registered company, MIDCEMB Healthcare Ltd. This joint venture focuses on the commercialization of stem cells, biopharmaceutical products, and cost-effective genetic diagnostics developed at CEMB. 

The initiative was prominently showcased at an event organized by the Pakistan Pharmaceuticals Manufacturers Association (PPMA) at the Expo Centre from January 20th to 22nd, 2025. By advancing these innovative healthcare solutions, the collaboration aims to make cutting-edge research more accessible, underscoring CEMB’s commitment to improving healthcare affordability and availability in Pakistan.